BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 6654793)

  • 1. Adjuvant therapy of chronic refractory cardiac failure with oral hydralazine and isosorbide dinitrate.
    Kothiala A; Ramnani K; Patel HR; Mehta NC; Shah CP
    J Assoc Physicians India; 1983 Jun; 31(6):343-6. PubMed ID: 6654793
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of vasodilator therapy on mortality in chronic congestive heart failure. Results of a Veterans Administration Cooperative Study.
    Cohn JN; Archibald DG; Ziesche S; Franciosa JA; Harston WE; Tristani FE; Dunkman WB; Jacobs W; Francis GS; Flohr KH
    N Engl J Med; 1986 Jun; 314(24):1547-52. PubMed ID: 3520315
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnosis and management of chronic heart failure.
    Aguiar-Souto P; Garcia-Pavia P; Silva-Melchor L; Ortigosa FJ
    J Am Coll Cardiol; 2006 Jul; 48(1):223; author reply 224. PubMed ID: 16814680
    [No Abstract]   [Full Text] [Related]  

  • 4. [Hemodynamic effects of oral dihydralazine and sublingual isosorbide dinitrate, alone and in combination in chronic heart failure].
    Page A; Larnaudie B; Pic A; Videau P; Besse P
    Arch Mal Coeur Vaiss; 1979 Dec; 72(12):1367-75. PubMed ID: 120154
    [No Abstract]   [Full Text] [Related]  

  • 5. Veterans Administration Cooperative Study on Vasodilator Therapy of Heart Failure: influence of prerandomization variables on the reduction of mortality by treatment with hydralazine and isosorbide dinitrate.
    Cohn JN; Archibald DG; Francis GS; Ziesche S; Franciosa JA; Harston WE; Tristani FE; Dunkman WB; Jacobs W; Flohr KH
    Circulation; 1987 May; 75(5 Pt 2):IV49-54. PubMed ID: 3552302
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure.
    Cohn JN; Johnson G; Ziesche S; Cobb F; Francis G; Tristani F; Smith R; Dunkman WB; Loeb H; Wong M
    N Engl J Med; 1991 Aug; 325(5):303-10. PubMed ID: 2057035
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of vasodilator therapy on mortality in chronic congestive heart failure.
    Ghose JC; Chakraborty S; Mondal M; Bhandari B
    J Assoc Physicians India; 1993 May; 41(5):269-71. PubMed ID: 8300456
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Vasodilator drugs in the therapy of chronic congestive heart failure. Clinico-case contribution].
    Artese D; Albani A; Di Tomasso E
    Minerva Med; 1983 Mar; 74(13):715-22. PubMed ID: 6220231
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Long-term vasodilator therapy of chronic refractory heart failure in patients with dilated cardiomyopathy].
    Moriuchi M; Saito S; Tamura Y; Kaseda N; Tsuji M; Tokutake E; Yumikura S; Hibiya K; Ozawa Y; Hatano M
    J Cardiogr Suppl; 1986; (9):77-85. PubMed ID: 3093596
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison between the effects of diltiazem and isosorbide dinitrate on digoxin pharmacodynamics and kinetics in the treatment of patients with chronic ischemic heart failure.
    Mahgoub AA; El-Medany AH; Abdulatif AS
    Saudi Med J; 2002 Jun; 23(6):725-31. PubMed ID: 12070557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Long-term effects of digoxin and hydralazine in patients with chronic cardiac insufficiency].
    Corbalán R; Arriagada D; Rodríguez JA; Chamorro G; Meleda I; Casanegra P; Valenzuela P
    Rev Med Chil; 1985 Oct; 113(10):947-53. PubMed ID: 3837287
    [No Abstract]   [Full Text] [Related]  

  • 12. [Effect of peripheral vasodilators on thrombocyte aggregation in chronic circulatory insufficiency].
    Kirichenko LL; Gaĭdukova NI; Solov'eva FV
    Sov Med; 1986; (2):91-4. PubMed ID: 3704769
    [No Abstract]   [Full Text] [Related]  

  • 13. [Treatment of advanced heart failure with hydralazine and isosorbide dinitrate (author's transl)].
    Lanas F; Salvatici R; Opazo JA; Saavedra J; Iturriaga J
    Rev Med Chil; 1979 Oct; 107(10):926-30. PubMed ID: 550229
    [No Abstract]   [Full Text] [Related]  

  • 14. Fixed-dose isosorbide dinitrate-hydralazine: race-based cardiovascular medicine benefit or mirage?
    Ferdinand KC
    J Law Med Ethics; 2008; 36(3):458-63. PubMed ID: 18840236
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Update on outpatient treatment of systolic heart failure.
    Fiscella K
    Am Fam Physician; 2005 Oct; 72(7):1172, 1174. PubMed ID: 16225019
    [No Abstract]   [Full Text] [Related]  

  • 16. [Vasodilator therapy in congestive heart failure--hemodynamic effects of oral administered isosorbide dinitrate (author's transl)].
    Osamura Y; Takahashi S; Nakai K; Kimata S; Ogawa T; Hirosawa K
    Kokyu To Junkan; 1978 Jul; 26(7):677-83. PubMed ID: 674893
    [No Abstract]   [Full Text] [Related]  

  • 17. Combined oral hydralazine-nitrate therapy in left ventricular failure. Hemodynamic equivalency to sodium nitroprusside.
    Pierpont GL; Cohn JN; Franciosa JA
    Chest; 1978 Jan; 73(1):8-13. PubMed ID: 620563
    [No Abstract]   [Full Text] [Related]  

  • 18. Hemodynamic advantage of combined administration of hydralazine orally and nitrates nonparenterally in the vasodilator therapy of chronic heart failure.
    Massie B; Chatterjee K; Werner J; Greenberg B; Hart R; Parmley WW
    Am J Cardiol; 1977 Nov; 40(5):794-801. PubMed ID: 411364
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Use of peripheral vasodilators with different mechanisms of action in treating heart failure patients].
    Novikov SV; Mareev VIu; Elizarova NA; Naumov VG; Sazonova LN
    Ter Arkh; 1987; 59(9):126-30. PubMed ID: 3424177
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined vasodilator therapy in the treatment of chronic heart failure.
    McGuinness JB; Ballantyne D; Baxter RH; Clark RS; Weir JI
    Ann Acad Med Singap; 1981 Oct; 10(4 Suppl):43-4. PubMed ID: 7344601
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.